Enable JavaScript to visit this website.

What is XELJANZ?

XELJANZ (tofacitinib) is a prescription medicine called a Janus kinase (JAK) inhibitor used to treat:

  • Adults with moderately to severely active ulcerative colitis when medicines called tumor necrosis factor (TNF) blockers did not work well or cannot be tolerated

It is not known if XELJANZ is safe and effective in children or in people with Hepatitis B or C.

XELJANZ is not recommended for people with severe liver problems.

If I have been prescribed XELJANZ, am I eligible to receive a free trial offer?

If you are new to XELJANZ, your healthcare provider can request, or provide to you during your appointment, a 30-day trial prescription. Terms and conditions/eligibility requirements apply.